Is HNGZY or SCHD a better dividend investment in 2026?

HNGZY currently yields 0.72% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: SCHD offers higher current income.

What is the dividend yield difference between HNGZY and SCHD?

HNGZY has a forward dividend yield of 0.72% ($0.03/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 2.72 percentage points.

Home › Compare › HNGZY vs SCHD

HNGZY vs SCHD: Dividend Comparison 2026

HNGZY yields 0.72% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HNGZY wins by $1.65M in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

HNGZY

● Live price

0.72%

Share price

$4.00

Annual div

$0.03

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.68M

Annual income

$1,324,338.59

Full HNGZY calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — HNGZY vs SCHD

📍 HNGZY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HNGZY	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HNGZY + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HNGZY pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNGZY

Annual income on $10K today (after 15% tax)

$61.54/yr

After 10yr DRIP, annual income (after tax)

$1,125,687.80/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, HNGZY beats the other by $1,125,328.58/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNGZY + SCHD for your $10,000?

HNGZY: 50%SCHD: 50%

100% SCHD50/50100% HNGZY

Portfolio after 10yr

$852.3K

Annual income

$662,380.59/yr

Blended yield

77.71%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNGZY buys

SCHD buys

No recent congressional trades found for HNGZY or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHNGZYSCHD

Forward yield	0.72%	3.44% ✓
Annual dividend / share	$0.03	$1.06 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$1.68M	$29.0K ✓
Annual income after 10y	$1,324,338.59 ✓	$422.61
Total dividends collected	$1.62M	$3.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HNGZY vs SCHD ($10,000, DRIP)

Year	HNGZY Portfolio	HNGZY Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1	$10,845	$144.81	$11,224	$344.10	$379.00 → SCHD
2	$11,897	$293.53	$12,567	$354.98	$670.00 → SCHD
3	$13,332	$601.91	$14,038	$365.30	$706.00 → SCHD
4	$15,526	$1,260.74	$15,648	$375.06	$122.00 → SCHD
5← crossover	$19,357	$2,744.31	$17,410	$384.27	+$1.9K → HNGZY
6	$27,108	$6,395.29	$19,335	$392.95	+$7.8K → HNGZY
7	$45,745	$16,739.89	$21,437	$401.10	+$24.3K → HNGZY
8	$101,749	$52,802.12	$23,733	$408.75	+$78.0K → HNGZY
9	$328,397	$219,525.46	$26,237	$415.91	+$302.2K → HNGZY
10	$1,675,724	$1,324,338.59	$28,968	$422.61	+$1.65M → HNGZY

HNGZY vs SCHD: Complete Analysis 2026

HNGZY — Stock

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Full HNGZY Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this HNGZY vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNGZY vs JEPI HNGZY vs O HNGZY vs KO HNGZY vs MAIN HNGZY vs VYM HNGZY vs DGRO HNGZY vs VIG HNGZY vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.